Skip to main content
Top
Published in: Current Diabetes Reports 1/2016

01-01-2016 | Hospital Management of Diabetes (GE Umpierrez, Section Editor)

Hyperglycemia and Acute Kidney Injury During the Perioperative Period

Authors: Carlos E. Mendez, Paul J. Der Mesropian, Roy O. Mathew, Barbara Slawski

Published in: Current Diabetes Reports | Issue 1/2016

Login to get access

Abstract

Hyperglycemia and acute kidney injury (AKI) are frequently observed during the perioperative period. Substantial evidence indicates that hyperglycemia increases the prevalence of AKI as a surgical complication. Patients who develop hyperglycemia and AKI during the perioperative period are at significantly elevated risk for poor outcomes such as major adverse cardiac events and all-cause mortality. Early observational and interventional trials demonstrated that the use of intensive insulin therapy to achieve strict glycemic control resulted in remarkable reductions of AKI in surgical populations. However, more recent interventional trials and meta-analyses have produced contradictory evidence questioning the renal benefits of strict glycemic control. Although the exact mechanisms through which hyperglycemia increases the risk of AKI have not been elucidated, multiple pathophysiologic pathways have been proposed. Hypoglycemia and glycemic variability may also play a significant role in the development of AKI. In this literature review, the complex relationship between hyperglycemia and AKI as well as its impact on clinical outcomes during the perioperative period is explored.
Literature
3.
go back to reference Schmeltz LR, DeSantis AJ, Thiyagarajan V, et al. Reduction of surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management strategy. Diabetes Care. 2007;30(4):823–8.PubMedCrossRef Schmeltz LR, DeSantis AJ, Thiyagarajan V, et al. Reduction of surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management strategy. Diabetes Care. 2007;30(4):823–8.PubMedCrossRef
4.••
go back to reference van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359–67. doi:10.1056/NEJMoa011300. This study provided early evidence on the beneficial effects of intensive insulin therapy on acute kidney injury in critically ill surgical patients.PubMedCrossRef van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359–67. doi:10.​1056/​NEJMoa011300. This study provided early evidence on the beneficial effects of intensive insulin therapy on acute kidney injury in critically ill surgical patients.PubMedCrossRef
5.
6.
go back to reference Clement S, Braithwaite SS, Magee MF, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27(2):553–91.PubMedCrossRef Clement S, Braithwaite SS, Magee MF, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27(2):553–91.PubMedCrossRef
8.
go back to reference Kiran RP, Turina M, Hammel J, et al. The clinical significance of an elevated postoperative glucose value in nondiabetic patients after colorectal surgery: evidence for the need for tight glucose control? Ann Surg. 2013;258(4):599–604. doi:10.1097/SLA.0b013e3182a501e3. discussion 604–5.PubMed Kiran RP, Turina M, Hammel J, et al. The clinical significance of an elevated postoperative glucose value in nondiabetic patients after colorectal surgery: evidence for the need for tight glucose control? Ann Surg. 2013;258(4):599–604. doi:10.​1097/​SLA.​0b013e3182a501e3​. discussion 604–5.PubMed
10.
go back to reference Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125(5):1007–21. doi:10.1067/mtc.2003.181.PubMedCrossRef Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125(5):1007–21. doi:10.​1067/​mtc.​2003.​181.PubMedCrossRef
11.
go back to reference Estrada CA, Young JA, Nifong LW, et al. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg. 2003;75(5):1392–9.PubMedCrossRef Estrada CA, Young JA, Nifong LW, et al. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg. 2003;75(5):1392–9.PubMedCrossRef
13.
go back to reference McAlister FA, Majumdar SR, Blitz S, et al. The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care. 2005;28(4):810–5.PubMedCrossRef McAlister FA, Majumdar SR, Blitz S, et al. The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care. 2005;28(4):810–5.PubMedCrossRef
14.
go back to reference Omar AS, Salama A, Allam M, et al. Association of time in blood glucose range with outcomes following cardiac surgery. BMC Anesthesiol. 2015;15:14-2253-15-14. eCollection. doi: 10.1186/1471-2253-15-14 . Omar AS, Salama A, Allam M, et al. Association of time in blood glucose range with outcomes following cardiac surgery. BMC Anesthesiol. 2015;15:14-2253-15-14. eCollection. doi: 10.​1186/​1471-2253-15-14 .
16.•
go back to reference Ata A, Lee J, Bestle SL, et al. Postoperative hyperglycemia and surgical site infection in general surgery patients. Arch Surg. 2010;145(9):858–64. doi:10.1001/archsurg.2010.179. This study isolated hyperglycemia as the strongest risk predictor for surgical site infections in a large general surgical population.PubMedCrossRef Ata A, Lee J, Bestle SL, et al. Postoperative hyperglycemia and surgical site infection in general surgery patients. Arch Surg. 2010;145(9):858–64. doi:10.​1001/​archsurg.​2010.​179. This study isolated hyperglycemia as the strongest risk predictor for surgical site infections in a large general surgical population.PubMedCrossRef
20.
22.
go back to reference Mases A, Sabate S, Guilera N, et al. Preoperative estimated glomerular filtration rate and the risk of major adverse cardiovascular and cerebrovascular events in non-cardiac surgery. Br J Anaesth. 2014;113(4):644–51. doi:10.1093/bja/aeu134.PubMedCrossRef Mases A, Sabate S, Guilera N, et al. Preoperative estimated glomerular filtration rate and the risk of major adverse cardiovascular and cerebrovascular events in non-cardiac surgery. Br J Anaesth. 2014;113(4):644–51. doi:10.​1093/​bja/​aeu134.PubMedCrossRef
24.
go back to reference Hou SH, Bushinsky DA, Wish JB, et al. Hospital-acquired renal insufficiency: a prospective study. Am J Med. 1983;74(2):243–8.PubMedCrossRef Hou SH, Bushinsky DA, Wish JB, et al. Hospital-acquired renal insufficiency: a prospective study. Am J Med. 1983;74(2):243–8.PubMedCrossRef
26.
go back to reference Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute dialysis quality initiative (ADQI) group. Crit Care. 2004;8(4):R204–12. doi:10.1186/cc2872.PubMedCentralPubMedCrossRef Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute dialysis quality initiative (ADQI) group. Crit Care. 2004;8(4):R204–12. doi:10.​1186/​cc2872.PubMedCentralPubMedCrossRef
27.
go back to reference Mehta RL, Kellum JA, Shah SV, et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31.PubMedCentralPubMedCrossRef Mehta RL, Kellum JA, Shah SV, et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31.PubMedCentralPubMedCrossRef
30.
go back to reference Bagdade JD, Root RK, Bulger RJ. Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes. 1974;23(1):9–15.PubMedCrossRef Bagdade JD, Root RK, Bulger RJ. Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes. 1974;23(1):9–15.PubMedCrossRef
31.
go back to reference Edwards FH, Grover FL, Shroyer AL, et al. The Society of Thoracic Surgeons National Cardiac Surgery Database: current risk assessment. Ann Thorac Surg. 1997;63(3):903–8.PubMedCrossRef Edwards FH, Grover FL, Shroyer AL, et al. The Society of Thoracic Surgeons National Cardiac Surgery Database: current risk assessment. Ann Thorac Surg. 1997;63(3):903–8.PubMedCrossRef
33.•
go back to reference Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615–25. This article describes the pathophysiologic basis of tissue injury associated with hyperglycemia.PubMedCrossRef Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615–25. This article describes the pathophysiologic basis of tissue injury associated with hyperglycemia.PubMedCrossRef
36.
go back to reference Ellger B, Debaveye Y, Vanhorebeek I, et al. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes. 2006;55(4):1096–105.PubMedCrossRef Ellger B, Debaveye Y, Vanhorebeek I, et al. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes. 2006;55(4):1096–105.PubMedCrossRef
37.
38.
go back to reference Cherney DZ, Scholey JW, Sochett E, et al. The acute effect of clamped hyperglycemia on the urinary excretion of inflammatory cytokines/chemokines in uncomplicated type 1 diabetes: a pilot study. Diabetes Care. 2011;34(1):177–80. doi:10.2337/dc10-1219.PubMedCentralPubMedCrossRef Cherney DZ, Scholey JW, Sochett E, et al. The acute effect of clamped hyperglycemia on the urinary excretion of inflammatory cytokines/chemokines in uncomplicated type 1 diabetes: a pilot study. Diabetes Care. 2011;34(1):177–80. doi:10.​2337/​dc10-1219.PubMedCentralPubMedCrossRef
39.
go back to reference Quagliaro L, Piconi L, Assaloni R, et al. Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production. Atherosclerosis. 2005;183(2):259–67.PubMedCrossRef Quagliaro L, Piconi L, Assaloni R, et al. Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production. Atherosclerosis. 2005;183(2):259–67.PubMedCrossRef
40.
go back to reference Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295(14):1681–7.PubMedCrossRef Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295(14):1681–7.PubMedCrossRef
41.
go back to reference Horvath EM, Benko R, Kiss L, et al. Rapid ‘glycaemic swings’ induce nitrosative stress, activate poly(ADP-ribose) polymerase and impair endothelial function in a rat model of diabetes mellitus. Diabetologia. 2009;52(5):952–61. doi:10.1007/s00125-009-1304-0.PubMedCrossRef Horvath EM, Benko R, Kiss L, et al. Rapid ‘glycaemic swings’ induce nitrosative stress, activate poly(ADP-ribose) polymerase and impair endothelial function in a rat model of diabetes mellitus. Diabetologia. 2009;52(5):952–61. doi:10.​1007/​s00125-009-1304-0.PubMedCrossRef
44.
go back to reference Gandhi GY, Nuttall GA, Abel MD, et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc. 2005;80(7):862–6. Gandhi GY, Nuttall GA, Abel MD, et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc. 2005;80(7):862–6.
45.
go back to reference Ouattara A, Lecomte P, Le Manach Y, et al. Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology. 2005;103(4):687–94. Ouattara A, Lecomte P, Le Manach Y, et al. Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology. 2005;103(4):687–94.
46.
go back to reference Bhamidipati CM, LaPar DJ, Stukenborg GJ, et al. Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2011;141(2):543–51. Bhamidipati CM, LaPar DJ, Stukenborg GJ, et al. Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2011;141(2):543–51.
47.
go back to reference Subramaniam B, Lerner A, Novack V, et al. Increased glycemic variability in patients with elevated preoperative HbA1C predicts adverse outcomes following coronary artery bypass grafting surgery. Anesth Analg. 2014;118(2):277–87. Subramaniam B, Lerner A, Novack V, et al. Increased glycemic variability in patients with elevated preoperative HbA1C predicts adverse outcomes following coronary artery bypass grafting surgery. Anesth Analg. 2014;118(2):277–87.
48.
go back to reference Mangano CM, Diamondstone LS, Ramsay JG, et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The multicenter study of perioperative ischemia research group. Ann Intern Med. 1998;128(3):194–203.PubMedCrossRef Mangano CM, Diamondstone LS, Ramsay JG, et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The multicenter study of perioperative ischemia research group. Ann Intern Med. 1998;128(3):194–203.PubMedCrossRef
51.
go back to reference Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1(1):19–32.PubMedCrossRef Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1(1):19–32.PubMedCrossRef
53.
go back to reference Palomba H, de Castro I, Neto AL, et al. Acute kidney injury prediction following elective cardiac surgery: AKICS score. Kidney Int. 2007;72(5):624–31.PubMedCrossRef Palomba H, de Castro I, Neto AL, et al. Acute kidney injury prediction following elective cardiac surgery: AKICS score. Kidney Int. 2007;72(5):624–31.PubMedCrossRef
56.
go back to reference Oezkur M, Wagner M, Weismann D, et al. Chronic hyperglycemia is associated with acute kidney injury in patients undergoing CABG surgery—a cohort study. BMC Cardiovasc Disord. 2015;15:41-015-0028-y. doi:10.1186/s12872-015-0028-y. Oezkur M, Wagner M, Weismann D, et al. Chronic hyperglycemia is associated with acute kidney injury in patients undergoing CABG surgery—a cohort study. BMC Cardiovasc Disord. 2015;15:41-015-0028-y. doi:10.​1186/​s12872-015-0028-y.
57.•
go back to reference Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med. 2003;31(2):359–66. doi:10.1097/01.CCM.0000045568.12881.10. This study proposed insulin dosage as an independent determinant of acute kidney injury.PubMedCrossRef Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med. 2003;31(2):359–66. doi:10.​1097/​01.​CCM.​0000045568.​12881.​10. This study proposed insulin dosage as an independent determinant of acute kidney injury.PubMedCrossRef
58.
go back to reference Ingels C, Debaveye Y, Milants I, et al. Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life. Eur Heart J. 2006;27(22):2716–24.PubMedCrossRef Ingels C, Debaveye Y, Milants I, et al. Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life. Eur Heart J. 2006;27(22):2716–24.PubMedCrossRef
61.
go back to reference Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes. 2006;55(11):3151–9.PubMedCrossRef Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes. 2006;55(11):3151–9.PubMedCrossRef
62.
go back to reference Garber AJ, Moghissi ES, Bransome Jr ED, et al. American college of endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2004;10(1):77–82.PubMedCrossRef Garber AJ, Moghissi ES, Bransome Jr ED, et al. American college of endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2004;10(1):77–82.PubMedCrossRef
63.••
go back to reference Gandhi GY, Nuttall GA, Abel MD, et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med. 2007;146(4):233–43. This study found no advantage of intensive intraoperative insulin therapy in the prevention of acute kidney injury.PubMedCrossRef Gandhi GY, Nuttall GA, Abel MD, et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med. 2007;146(4):233–43. This study found no advantage of intensive intraoperative insulin therapy in the prevention of acute kidney injury.PubMedCrossRef
64.
go back to reference Jones KW, Cain AS, Mitchell JH, et al. Hyperglycemia predicts mortality after CABG: postoperative hyperglycemia predicts dramatic increases in mortality after coronary artery bypass graft surgery. J Diabet Complications. 2008;22(6):365–70. doi:10.1016/j.jdiacomp.2007.05.006.CrossRef Jones KW, Cain AS, Mitchell JH, et al. Hyperglycemia predicts mortality after CABG: postoperative hyperglycemia predicts dramatic increases in mortality after coronary artery bypass graft surgery. J Diabet Complications. 2008;22(6):365–70. doi:10.​1016/​j.​jdiacomp.​2007.​05.​006.CrossRef
66.
go back to reference Subramaniam B, Panzica PJ, Novack V, et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology. 2009;110(5):970–7. doi:10.1097/ALN.0b013e3181a1005b.PubMedCrossRef Subramaniam B, Panzica PJ, Novack V, et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology. 2009;110(5):970–7. doi:10.​1097/​ALN.​0b013e3181a1005b​.PubMedCrossRef
68.
go back to reference Kim WH, Park MH, Kim HJ, et al. Potentially modifiable risk factors for acute kidney injury after surgery on the thoracic aorta: a propensity score matched case–control study. Medicine (Baltimore). 2015;94(2), e273. doi:10.1097/MD.0000000000000273.CrossRef Kim WH, Park MH, Kim HJ, et al. Potentially modifiable risk factors for acute kidney injury after surgery on the thoracic aorta: a propensity score matched case–control study. Medicine (Baltimore). 2015;94(2), e273. doi:10.​1097/​MD.​0000000000000273​.CrossRef
69.
go back to reference Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004;79(8):992–1000.PubMedCrossRef Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004;79(8):992–1000.PubMedCrossRef
70.
go back to reference Lecomte P, Van Vlem B, Coddens J, et al. Tight perioperative glucose control is associated with a reduction in renal impairment and renal failure in non-diabetic cardiac surgical patients. Crit Care. 2008;12(6):R154. doi:10.1186/cc7145.PubMedCentralPubMedCrossRef Lecomte P, Van Vlem B, Coddens J, et al. Tight perioperative glucose control is associated with a reduction in renal impairment and renal failure in non-diabetic cardiac surgical patients. Crit Care. 2008;12(6):R154. doi:10.​1186/​cc7145.PubMedCentralPubMedCrossRef
72.
go back to reference De La Rosa Gdel C, Donado JH, Restrepo AH, et al. Grupo de investigacion en cuidado intensivo: GICI-HPTU. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit Care. 2008;12(5):R120.CrossRef De La Rosa Gdel C, Donado JH, Restrepo AH, et al. Grupo de investigacion en cuidado intensivo: GICI-HPTU. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit Care. 2008;12(5):R120.CrossRef
73.••
go back to reference NICE-SUGAR Study Investigators, Finfer S, Chittock DR, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283–97. doi:10.1056/NEJMoa0810625. This study found no significant difference in renal replacement therapy utilization between intensive and conventional glucose management.CrossRef NICE-SUGAR Study Investigators, Finfer S, Chittock DR, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283–97. doi:10.​1056/​NEJMoa0810625. This study found no significant difference in renal replacement therapy utilization between intensive and conventional glucose management.CrossRef
74.
go back to reference Thomas G, Rojas MC, Epstein SK, et al. Insulin therapy and acute kidney injury in critically ill patients a systematic review. Nephrol Dial Transplant. 2007;22(10):2849–55.PubMedCrossRef Thomas G, Rojas MC, Epstein SK, et al. Insulin therapy and acute kidney injury in critically ill patients a systematic review. Nephrol Dial Transplant. 2007;22(10):2849–55.PubMedCrossRef
77.
go back to reference Chan RP, Galas FR, Hajjar LA, et al. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo). 2009;64(1):51–60.CrossRef Chan RP, Galas FR, Hajjar LA, et al. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo). 2009;64(1):51–60.CrossRef
78.
go back to reference Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009;35(10):1738–48. doi:10.1007/s00134-009-1585-2.PubMedCrossRef Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009;35(10):1738–48. doi:10.​1007/​s00134-009-1585-2.PubMedCrossRef
80.
go back to reference Azevedo JR, Azevedo RP, Lucena LC, et al. Impact of glycemic control on the incidence of acute kidney injury in critically ill patients: a comparison of two strategies using the RIFLE criteria. Clinics (Sao Paulo). 2010;65(8):769–73.CrossRef Azevedo JR, Azevedo RP, Lucena LC, et al. Impact of glycemic control on the incidence of acute kidney injury in critically ill patients: a comparison of two strategies using the RIFLE criteria. Clinics (Sao Paulo). 2010;65(8):769–73.CrossRef
81.••
go back to reference Umpierrez GE, Smiley D, Jacobs S, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care. 2011;34(2):256–61. doi:10.2337/dc10-1407. This study found a reduction in acute renal failure in surgical patients treated with basal bolus compared to sliding scale insulin.PubMedCentralPubMedCrossRef Umpierrez GE, Smiley D, Jacobs S, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care. 2011;34(2):256–61. doi:10.​2337/​dc10-1407. This study found a reduction in acute renal failure in surgical patients treated with basal bolus compared to sliding scale insulin.PubMedCentralPubMedCrossRef
82.•
go back to reference Baldwin D, Zander J, Munoz C, et al. A randomized trial of two weight-based doses of insulin glargine and glulisine in hospitalized subjects with type 2 diabetes and renal insufficiency. Diabetes Care. 2012;35(10):1970–4. doi:10.2337/dc12-0578. This study demonstrated lower rates of hypoglycemia with reduced subcutaneous insulin dose for patients with renal failure.PubMedCentralPubMedCrossRef Baldwin D, Zander J, Munoz C, et al. A randomized trial of two weight-based doses of insulin glargine and glulisine in hospitalized subjects with type 2 diabetes and renal insufficiency. Diabetes Care. 2012;35(10):1970–4. doi:10.​2337/​dc12-0578. This study demonstrated lower rates of hypoglycemia with reduced subcutaneous insulin dose for patients with renal failure.PubMedCentralPubMedCrossRef
85.•
go back to reference Mendez CE, Mok KT, Ata A, et al. Increased glycemic variability is independently associated with length of stay and mortality in noncritically ill hospitalized patients. Diabetes Care. 2013;36(12):4091–7. doi:10.2337/dc12-2430. This study found an independent association between increased glycemic variability and length of stay and 90-day mortality.PubMedCentralPubMedCrossRef Mendez CE, Mok KT, Ata A, et al. Increased glycemic variability is independently associated with length of stay and mortality in noncritically ill hospitalized patients. Diabetes Care. 2013;36(12):4091–7. doi:10.​2337/​dc12-2430. This study found an independent association between increased glycemic variability and length of stay and 90-day mortality.PubMedCentralPubMedCrossRef
89.
go back to reference Desouza C, Salazar H, Cheong B, et al. Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring. Diabetes Care. 2003;26(5):1485–9.PubMedCrossRef Desouza C, Salazar H, Cheong B, et al. Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring. Diabetes Care. 2003;26(5):1485–9.PubMedCrossRef
92.
go back to reference Hermayer KL, Egidi MF, Finch NJ, et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. J Clin Endocrinol Metab. 2012;97(12):4399–406. doi:10.1210/jc.2012-1979.PubMedCrossRef Hermayer KL, Egidi MF, Finch NJ, et al. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. J Clin Endocrinol Metab. 2012;97(12):4399–406. doi:10.​1210/​jc.​2012-1979.PubMedCrossRef
95.••
go back to reference Fiaccadori E, Sabatino A, Morabito S, et al. Hyper/hypoglycemia and acute kidney injury in critically ill patients. Clin Nutr. 2015. doi:10.1016/j.clnu.2015.04.006. This article described the complex relationship between hypoglycemia and acute kidney injury.PubMed Fiaccadori E, Sabatino A, Morabito S, et al. Hyper/hypoglycemia and acute kidney injury in critically ill patients. Clin Nutr. 2015. doi:10.​1016/​j.​clnu.​2015.​04.​006. This article described the complex relationship between hypoglycemia and acute kidney injury.PubMed
97.
go back to reference Kidney Disease: Improving Global Outcomes (KDIGO). Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int. 2012;2 Suppl 1:138. Kidney Disease: Improving Global Outcomes (KDIGO). Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int. 2012;2 Suppl 1:138.
98.
go back to reference Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2012;143(1):4–34. doi:10.1016/j.jtcvs.2011.10.015.PubMedCrossRef Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2012;143(1):4–34. doi:10.​1016/​j.​jtcvs.​2011.​10.​015.PubMedCrossRef
99.
go back to reference Duncan AI, Koch CG, Xu M, et al. Recent metformin ingestion does not increase in-hospital morbidity or mortality after cardiac surgery. Anesth Analg. 2007;104(1):42–50.PubMedCrossRef Duncan AI, Koch CG, Xu M, et al. Recent metformin ingestion does not increase in-hospital morbidity or mortality after cardiac surgery. Anesth Analg. 2007;104(1):42–50.PubMedCrossRef
100.
go back to reference Mercker SK, Maier C, Neumann G, et al. Lactic acidosis as a serious perioperative complication of antidiabetic biguanide medication with metformin. Anesthesiology. 1997;87(4):1003–5.PubMedCrossRef Mercker SK, Maier C, Neumann G, et al. Lactic acidosis as a serious perioperative complication of antidiabetic biguanide medication with metformin. Anesthesiology. 1997;87(4):1003–5.PubMedCrossRef
101.
go back to reference Sandler V, Misiasz MR, Jones J, et al. Reducing the risk of hypoglycemia associated with intravenous insulin: experience with a computerized insulin infusion program in 4 adult intensive care units. J Diabet Sci Technol. 2014;8(5):923–9. doi:10.1177/1932296814540870.CrossRef Sandler V, Misiasz MR, Jones J, et al. Reducing the risk of hypoglycemia associated with intravenous insulin: experience with a computerized insulin infusion program in 4 adult intensive care units. J Diabet Sci Technol. 2014;8(5):923–9. doi:10.​1177/​1932296814540870​.CrossRef
102.
go back to reference Umpierrez GE, Hellman R, Korytkowski MT, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(1):16–38. doi:10.1210/jc.2011-2098.PubMedCrossRef Umpierrez GE, Hellman R, Korytkowski MT, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(1):16–38. doi:10.​1210/​jc.​2011-2098.PubMedCrossRef
103.••
go back to reference Zacharias M, Mugawar M, Herbison GP, et al. Interventions for protecting renal function in the perioperative period. Cochrane Database Syst Rev. 2013;9:CD003590. doi:10.1002/14651858.CD003590. This article examined interventions for the protection of acute kidney injury during the perioperative period.PubMed Zacharias M, Mugawar M, Herbison GP, et al. Interventions for protecting renal function in the perioperative period. Cochrane Database Syst Rev. 2013;9:CD003590. doi:10.​1002/​14651858.​CD003590. This article examined interventions for the protection of acute kidney injury during the perioperative period.PubMed
104.
go back to reference Palevsky PM. Perioperative management of patients with chronic kidney disease or ESRD. Best Pract Res Clin Anaesthesiol. 2004;18(1):129–44.PubMedCrossRef Palevsky PM. Perioperative management of patients with chronic kidney disease or ESRD. Best Pract Res Clin Anaesthesiol. 2004;18(1):129–44.PubMedCrossRef
105.
go back to reference Schoolwerth AC, Sica DA, Ballermann BJ, et al. Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association. Circulation. 2001;104(16):1985–91.PubMedCrossRef Schoolwerth AC, Sica DA, Ballermann BJ, et al. Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association. Circulation. 2001;104(16):1985–91.PubMedCrossRef
107.
go back to reference Arora P, Rajagopalam S, Ranjan R, et al. Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clin J Am Soc Nephrol. 2008;3(5):1266–73. doi:10.2215/CJN.05271107.PubMedCentralPubMedCrossRef Arora P, Rajagopalam S, Ranjan R, et al. Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clin J Am Soc Nephrol. 2008;3(5):1266–73. doi:10.​2215/​CJN.​05271107.PubMedCentralPubMedCrossRef
Metadata
Title
Hyperglycemia and Acute Kidney Injury During the Perioperative Period
Authors
Carlos E. Mendez
Paul J. Der Mesropian
Roy O. Mathew
Barbara Slawski
Publication date
01-01-2016
Publisher
Springer US
Published in
Current Diabetes Reports / Issue 1/2016
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-015-0701-7

Other articles of this Issue 1/2016

Current Diabetes Reports 1/2016 Go to the issue

Pharmacologic Treatment of Type 2 Diabetes (HE Lebovitz and G Bahtiyar, Section Editors)

GLP-1 and Amylin in the Treatment of Obesity

Diabetes Epidemiology (NM Maruthur, Section Editor)

Does Metformin Reduce Cancer Risks? Methodologic Considerations

Other Forms of Diabetes (JJ Nolan, Section Editor)

Wolfram Syndrome: Diagnosis, Management, and Treatment

Diabetes and Pregnancy (CJ Homko, Section Editor)

Is There a Role for HbA1c in Pregnancy?

Diabetes Epidemiology (NM Maruthur, Section Editor)

Type 2 Diabetes and Hearing Impairment

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.